Skip to main content
. 2019 Mar 14;9:4532. doi: 10.1038/s41598-019-40241-1

Figure 4.

Figure 4

In vivo anti-tumor efficacy of two antibody blockade both CD47 antibody and CD274 antibody in 4T1 tumor cells. (A) Flow cytometry sorting graphs showing how to distinguish unwanted noise from gated. (B) Schema for two antibodies blockade in immunotherapy. (C–E) The percent of T cells, NK cells and NKT cells in leukocyte since the start of the injection (*P < 0.05, **P < 0.01 and ***P < 0.001). (F–H) The percentage activation of T cells, NK cells and NKT cells after treatment.